5 cents. ASX - Day TradingCreated with Sketch. 1956773. 0 Great. Created with Sketch. Charts. Release Date: 20/03/23 08:11; Summary: German Approval for IIH EVOLVE Phase 3 Clinical Trial; Price Sensitive: Yes; Download Document 195. TRP also trades sub cash -5m i believe, haven't checked in a while. AX stock on Yahoo Finance. ASX - Day Trading. Zillow has 23383 homes for sale in British Columbia. Forums. Market Cap $16. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. . IXC Price at posting: 23. ASX - General. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 10 cents a week and we will be at $2 plus in no time. ASX - Short Term Trading. a shell trading below cash backing, ripe. 1. Market . Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). boolish Jellyroll hey. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. . Invex Granted Key European Patent for Exenatide, page-2. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. ASX - By Stock. Most bio's get acquired on P2 readouts, if results are strong early here. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. Created with Sketch. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. Latest Posts. 38 Biotechnology stocks are valued based on a risk. . ASX - Day Trading. , page-4. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. 1073084. Just another way to saying that we've got Patient 1 out of 240. , page-4. ASX - By Stock. . , page-196. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - General. Created with Sketch. 8M ! Add to my watchlist. ASX - By Stock. 63%. ASX - By Stock. Latest Posts. . Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. 026. Notice of Quarterly Investor Call. Top 20 remains holding 58% compared to 58. I think having this out we can discuss on the way. . 0. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Forums. 0. ASX - By Stock. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. Join the HotCopper ASX share market forum today for free. ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. Created with Sketch. ASX - By Stock. 4KB OECCreated with Sketch. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. ASX - By Stock. Forums. 333334. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. Forums. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Market . International Markets. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. Webinvest Pty Ltd<Olsb Unit A/C>. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - By Stock. We are a team of expert financial advisers each specialising in different, yet complementary areas. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Invex Granted Type C Meeting with FDA, page-3. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Liked by Jackie Cox-Ziegler, CPHR. Created with Sketch. 0. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. GW Ixc once again showing why you are the best mgmt team on the ASX . ASX - General. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC IXC chart IXC invex therapeutics ltd IXC chart 1 Last ralom 17,015 Posts. Market . . Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. ASX - By Stock. Market . Management have earmarked this a significant milestone - given they previously tied it to performance. ASX - Day TradingCreated with Sketch. . ASX - Short Term Trading. When can we expect some update or. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. Contrast that to data from Wales in 2017 which suggests that. Join the HotCopper ASX share market forum today for free. Is it just me or has IXC gone very quiet. , page-4. Created with Sketch. Notification of cessation of securities - IXC. ASX - By Stock. Market Cap $102. Australia's largest stock trading and investment forum Australia's #1 stock forumMay 18 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX THERAPEUTICS SEEKS TRADING HALT PENDING RELEASE ON RESULTS OF ITS PHASE II TRIAL & UNDERTAKING A. I see it at perhaps $5 prior to readout. . ASX - Day Trading. Latest Posts. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Last research or update on this I listened to was by FiftyOneCapital. ASX - Day TradingI bought some today at 44. Forums. ASX - Short Term Trading. . , page-2. Created with Sketch. . Information. 59). Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. ASX - By Stock. ASX - By Stock. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Created with Sketch. A new thread to put trading comments / reasoning / opinions in. Wouldn’t surprised me if they turn this company into something else if he keeps buyingCreated with Sketch. 64440. Learn more. Latest Posts. Forums. Join HotCopper today. IXC Price at posting. 31% more bullish than other Healthcare sector stocks. They have acted appropriately. ASX - Short Term Trading. ASX - By Stock. is there any news release, or SP increasing due to only the market showing interest, page-2. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. ASX - By Stock. I find this very intriguing and positive that in last few weeks about 1. Created with Sketch. Advertise on HotCopper. ASX - Short Term Trading. Loading. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. With a team of 68. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Invex Receives Approval for Paediatric Plan from the EMA, page-3. 1. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. ASX - By Stock. Join the HotCopper ASX share market forum today for free. Friday we moved 55% off 690k volume. 06KBNotification of cessation of securities - IXC. Top Smart Score Stocks. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. 0% $ODM 35. Discover historical prices for IXC. Notice of Annual General Meeting/Proxy Form, page-2. Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. Charts. Forums. . Charts. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumFound this article a while back although raises some decent points. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. Created with Sketch. Australian finance news, stock quotes, currency information and blogs Active Funds. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Spot on - filled the 1. Market . Created with Sketch. Forums. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. . . A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. ASX - Short Term Trading. Forums. Invex Therapeutics Ltd. Appendix 4C - quarterly* or having a go at doing so, page-30. Advertise. . . Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. A rolling snowball gathers snow as it falls down the hill . Last updated 10. Created with Sketch. . ASX - By Stock. ASX - Short Term Trading. sentiment based on opinions from HotCopper and others. 3¢. ASX - By Stock. ASX - Day Tradingis invex releasing 2. Created with Sketch. Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. , page-5. ASX - Day Trading. My understanding is that NEU went from around $1. About 90 percent of the U. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. 147,415. Created with Sketch. 8 Upvote Created with Sketch. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. ASX - Day Trading. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Created with Sketch. 6 Upvote. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. 0¢ Sentiment: Buy Disclosure: Held. , page-5. Most bio's get. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. IXC below Example of that is NEUInvestor Presentation, page-3. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Join the HotCopper ASX share market forum today for free. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. ASX - Short Term Trading. Created with Sketch. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. , page-6. ASX - By Stock. Charts. Join the HotCopper ASX share market forum today for free. wonder if the GLP-1 agonist referred to in this media release. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Very impressive. Transparency is our policy. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. . ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Probably been disappointed like all of usCreated with Sketch. IXC Valuation Report MST. Some people like to gamble on stocks, others invest. , page-3. ASX - General. Forex. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Last updated 10. ASX - Day Trading. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. Created with Sketch. , page-5. Market . . IXC Valuation Report MST. IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. Created with Sketch. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. IXC has alot of catching up to do. Some people like to gamble on stocks, others invest. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Charts. . With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. ASX - Day Trading0. ASX - By Stock. Join the HotCopper ASX share market. Latest Posts. Last edited by jellyroll: 27/02/23. Last edited by ejjwj: 28/06/23. About 90 percent of the U. It's essentially a cashed up shell company right now it. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. A new thread to put trading comments / reasoning / opinions in. Last updated 10. ASX - Day Trading. Invex Therapeutics Lists on ASXNo worries mate :), page-15. , page-3. Charts. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Invex Therapeutics Ltd. Created with Sketch. 1. Trading HaltDCF Valuation: IXC Intrinsic Value of $6. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. Last updated 15. Created with Sketch. Last updated 15. ASX - By Stock. ASX - General. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - By Stock. Latest Posts. Created with Sketch. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. Market . Share I've got no issues with it. Created with Sketch. Join the HotCopper ASX share market forum today for free. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. IXC Price at posting: 37. pause in tradingHere we go! AU and UK sites activated for immediate recruitment. DJPIN. Investor PresentationI would be worried about holding IXC if they had no more cash. ASX - Short Term Trading. Here come the vultures. 30 order I had out there for 2-3 weeks. IXC (ASX) Ann: Trading Halt - HotCopper. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. These are 2007 numbers. Forex. ASX - General. Created with Sketch. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. ASX - General. Met primary endpoints for phase 2 trials. 0. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. . sentiment based on opinions from HotCopper and others. . Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. ASX - Day TradingHere's a very good opportunity for people in Sydney. So your thesis is right on a long time time frame. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. 1 Upvote. 333334. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. IXC (ASX) Ann: Trading Halt - HotCopper. gov and there is lots of good information about the trial. Grabbed my first ever parcel in IXC yesterdy at 80c. Created with Sketch. 91%) As of 03:35PM EST. . ASX - By Stock.